We recognize and welcome UNAIDS and Executive Director’s commitments to work with countries to explore and create an enabling environment for the implementation of Trade-Related Aspects of Intellectual Property Rights (TRIPS) flexibilities. However, the Programme Coordinating Board NGO Delegation is very concerned that the supply of generic anti-retrovirals (ARVs), especially the newer, more optimal and forgiving treatment regimens, are under threat because of:















